Which statement regarding nicotine oral inhaler and nicotine patch combination therapy is accurate?

The statement indicating that nicotine oral inhaler and nicotine patch combination therapy has evidence-based support is accurate because extensive research and clinical studies have shown that combining these two forms of nicotine replacement therapy can enhance the likelihood of successfully quitting smoking. The combination addresses different aspects of nicotine addiction: the patch provides a steady, baseline level of nicotine to reduce withdrawal symptoms, while the inhaler allows for quicker relief of cravings. This dual approach has been demonstrated to be more effective than using either treatment alone, making it a well-supported option in smoking cessation guidelines.

In contrast, while some may perceive the combination therapy as costly, the effectiveness in facilitating cessation often justifies the expense for many individuals. Additionally, while it may not be as widely adopted as other methods, it is certainly not rare and continues to be an option for those who struggle with quitting. Thus, the combination's documented efficacy in helping individuals stop smoking is the key reason behind the evidence-based support.